Frontiers in Pharmacology | Drugs Outcomes Research and Policies

Original Research

Published on 14 Apr 2025

Off-label drug use in China after the Physician Law (2021): legal challenges and solutions

in Drugs Outcomes Research and Policies

Shenbao Liang
Fanxian Cai

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1547418

858 views

Original Research

Published on 14 Apr 2025

Optimization and impact of an evidence-based pre-audit prescription decision system in primary healthcare settings

in Drugs Outcomes Research and Policies

Xiao-Hui Yue
Lei Yang
Jing-Jing Zhong
Hong-Mei Liu
Dan Wang
Xue Tao
Gao-Feng Zheng

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1491810

1,058 views

Original Research

Published on 11 Apr 2025

From clinical trials to informing clinical decision-making: a review of patient-reported outcomes in nononcology medicines approved by the European Medicines Agency (2018–2022)

in Drugs Outcomes Research and Policies

Sarah Sauchelli
Courtney Levy
Ari Gnanasakthy
Vaidehi Dave
Lynda Doward
Kristina A. Fitzgerald
Robyn Carson

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1536401

1,948 views

Clinical Trial

Published on 11 Apr 2025

Efficacy and safety of intermittent intravenous doxercalciferol in the treatment of secondary hyperparathyroidism in Chinese patients on maintenance hemodialysis: a phase II, open-label, prospective, multicenter study

in Drugs Outcomes Research and Policies

Guang Yang
Yaoyu Huang
Yifei Ge
Xiangbao Yu
Li Liu
Li Xiang
Bin Liu
Chaoqing Gao
Changhua Liu
Yong Xu

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1574679

930 views

Original Research

Published on 10 Apr 2025

Impact of clinical pharmacist interventions on medication administration via enteral feeding tubes in a neurology ward: a pre- and post-educational prospective study

in Drugs Outcomes Research and Policies

Yunus Emre Ayhan
Ömer Faruk Özkanlı
Şeyma Gözelizmir
Anmar Al-Taie
Mesut Sancar
Ipek Midi

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1519835

1,041 views

Perspective

Published on 09 Apr 2025

Exploring the complexities of disproportionality analysis in pharmacovigilance: reflections on the READUS-PV guideline and a call to action

in Drugs Outcomes Research and Policies

Tarek A. Hammad
Melissa Naylor
Dona M. Ely
Simon Davies

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1573353

1,551 views

Original Research

Published on 08 Apr 2025

Potential inappropriate medications and drug–drug interactions in adverse drug reactions in the elderly: a retrospective study in a pharmacovigilance database

in Drugs Outcomes Research and Policies

Huaqiao Jiang
Yanhua Lin
Weifang Ren
Lina Lu
Xiaofang Tan
Xiaoqun Lv
Ning Zhang

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1546012

2,373 views

Original Research

Published on 08 Apr 2025

Assessment of competencies of clinical research professionals and proposals to improve clinical research in Portugal

in Drugs Outcomes Research and Policies

Mónica Bogas
Joana Antas
Cátia Magalhães
Mafalda Revige
Liliana Guerra
Cheila Ribeiro
Rita Cunha Eça
Filipa Nunes
Ana Lopes
Luís Costa

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1578955

1,433 views

Original Research

Published on 07 Apr 2025

Drug-therapy-related problems and pharmacist interventions in the medical ward in northeast Ethiopia: focus on types, acceptability, and impacts

in Drugs Outcomes Research and Policies

Bedilu Linger Endalifer
Yared Dergu Ayta
Abate Wondesen Tsigie
Yehualashet Teshome Wondmkun
Mekuanint Terefe Kassa
Gedefaw Getnet Amare
Yenesew Wudu Ejigu
Manaye Tamrie Derseh
Abyou Seyfu Ambaye

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1558864

849 views

Original Research

Published on 07 Apr 2025

Economic costs and medications for diabetes in older patients in Beijing, China: electronic insurance data analysis

in Drugs Outcomes Research and Policies

Yanhua Ma
Yan Zhao
Ran Wei
Jingtao Qiao
Jingyi Luo
Lina Zhang
Jie Zhang
Mingqun Deng
Yang Yu
Weihao Wang

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1549244

1,088 views

Original Research

Published on 03 Apr 2025

Argatroban in patients with acute ischemic stroke with early neurological deterioration: a cost-effectiveness analysis from the perspective of Chinese healthcare system

in Drugs Outcomes Research and Policies

Yu Xie
Liping Hu
Ping Xu
Xianbin Guo
Junxiu Cai
Min Pan
Jie Tang
Qingtao Gong
Rong Su
Yake Lou

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1470373

886 views

Original Research

Published on 03 Apr 2025

Anticoagulation quality with warfarin therapy, and associated factors among adult outpatients at public hospitals in nekemte town, western Ethiopia: a retrospective study

in Drugs Outcomes Research and Policies

Firafan Shuma Teka
Ayana Tadesse Korsa
Habte Gebeyehu Bayisa
Dechasa Befikadu W/Senbat
Refisa Shifera Beyene
Dinka Dugassa Iticha
Birbirsa Sefera Senbeta

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1544957

1,021 views

Original Research

Published on 02 Apr 2025

Development and validation of a Chinese insulin medication literacy scale for patients with diabetes mellitus

in Drugs Outcomes Research and Policies

Fangying Si
Tao Feng
Xiangfen Shi
Sufang Chen

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1477050

1,218 views

Original Research

Published on 02 Apr 2025

Overall compilation of adverse effects of non-steroidal anti-inflammatory drugs: a hypothesis-free systematic investigation using a nationwide cohort study

in Drugs Outcomes Research and Policies

Hyein Han
Du Hyun Ro
Hyuk-Soo Han
Sungho Won

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1539328

1,798 views
1 citation

Original Research

Published on 01 Apr 2025

Assessment of Gliflozins prescribing pattern in a United Arab Emirates tertiary-level care hospital

in Drugs Outcomes Research and Policies

Wessa Shenouda
Dixon Thomas
Omar Nabi
Seeba Zachariah

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1529528

1,399 views

Original Research

Published on 01 Apr 2025

Irisin protects against cerebral ischemia reperfusion injury in a SIRT3-dependent manner

in Drugs Outcomes Research and Policies

Yushuang Cong
Ruichun Guo
Chenglong Li
Qi Li
Sihua Qi

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1558457

1,295 views
1 citation